Zhu D, Li Y, Zhang Z, Xue Z, Hua Z, Luo X, Liu Y. Recent advances of nanotechnology-based tumor vessel-targeting strategies. J Nanobiotechnol. 2021;19(1):1–17.
Dellacherie MO, Seo BR, Mooney DJ. Macroscale biomaterials strategies for local immunomodulation. Nat Rev Mater. 2019;4(6):379–97.
Zhang X, Chen J, Wang W, Li X, Tan Y, Zhang X, Qian W. Treatment of central nervous system relapse in acute promyelocytic leukemia by venetoclax: a case report. Front Oncol. 2021. https://doi.org/10.3389/fonc.2021.693670.
Cao HY, Tao T, Shen XD, Bai L, Wan CL, Wu DP, Xue SL. Efficiency of anti-VEGF therapy in central nervous system AML relapse: a case report and literature review. Clin Case Rep. 2022;10(2):e05367.
Huang CW, Chuang CP, Chen YJ, Wang HY, Lin JJ, Huang CY, Huang FT. Integrin α2β1-targeting ferritin nanocarrier traverses the blood–brain barrier for effective glioma chemotherapy. J Nanobiotechnol. 2021;19(1):1–17.
Ho JS, Zhang Y. Wireless nanomedicine for brain tumors. Nat Nanotechnol. 2022;17(9):907–8.
Vanner RJ, Dobson SM, Gan OI, McLeod J, Schoof EM, Grandal I, Dick JE. Multiomic profiling of central nervous system leukemia identifies mRNA translation as a therapeutic targetblocking translation to target B-ALL CNS disease. Blood Cancer Discov. 2022;3(1):16–31.
Zhang S, Zhang S, Luo S, Tang P, Wan M, Wu D, Gao W. Ultrasound-assisted brain delivery of nanomedicines for brain tumor therapy: advance and prospect. J Nanobiotechnol. 2022;20(1):1–27.
Zhang Y, Yang WX. Tight junction between endothelial cells: the interaction between nanoparticles and blood vessels. Beilstein J Nanotechnol. 2016;7(1):675–84.
Jia X, Yuan Z, Yang Y, Huang X, Han N, Liu X, Lei H. Multi-functional self-assembly nanoparticles originating from small molecule natural product for oral insulin delivery through modulating tight junctions. J Nanobiotechnol. 2022;20(1):1–17.
Liu B, Yan W, Luo L, Wu S, Wang Y, Zhong Y, Wang G. Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia. J Nanobiotechnol. 2021;19(1):1–19.
Mitusova K, Peltek OO, Karpov TE, Muslimov AR, Zyuzin MV, Timin AS. Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches. J Nanobiotechnol. 2022;20(1):1–40.
Shilo M, Sharon A, Baranes K, Motiei M, Lellouche JPM, Popovtzer R. The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model. J Nanobiotechnol. 2015;13(1):1–7.
Wolak DJ, Thorne RG. Diffusion of macromolecules in the brain: implications for drug delivery. Mol Pharm. 2013;10(5):1492–504.
Wang T, Zhang H, Qiu W, Han Y, Liu H, Li Z. Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy. Bioactive materials. 2022;16:418–32.
Yang M, Li J, Gu P, Fan X. The application of nanoparticles in cancer immunotherapy: targeting tumor microenvironment. Bioactive materials. 2021;6(7):1973–87.
Aur RJ, Simone J, Hustu HO, Walters T, Borella L, Pratt C, Pinkel D. Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. Blood. 1971;37(3):272–81.
Zhang Y, Guo P, Ma Z, Lu P, Kebebe D, Liu Z. Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review. J Nanobiotechnol. 2021;19(1):1–22.
Zhou F, Wen Y, Jin R, Chen H. New attempts for central nervous infiltration of pediatric acute lymphoblastic leukemia. Cancer Metastasis Rev. 2019;38(4):657–71.
Yao H, Price TT, Cantelli G, Ngo B, Warner MJ, Olivere L, Sipkins DA. Leukaemia hijacks a neural mechanism to invade the central nervous system. Nature. 2018;560(7716):55–60.
Elbahlawan L, Galdo AM, Ribeiro RC. Pulmonary manifestations of hematologic and oncologic diseases in children. Pediatr Clin. 2021;68(1):61–80.
Kitchen P, Salman MM, Halsey AM, Clarke-Bland C, MacDonald JA, Ishida H, Bill RM. Targeting aquaporin-4 subcellular localization to treat central nervous system edema. Cell. 2020;181(4):784–99.
Wang J, Rong Y, Ji C, Lv C, Jiang D, Ge X, Fan J. MicroRNA-421–3p-abundant small extracellular vesicles derived from M2 bone marrow-derived macrophages attenuate apoptosis and promote motor function recovery via inhibition of mTOR in spinal cord injury. J Nanobiotechnol. 2020;18(1):1–17.
Stewart DJ, Keating MJ, McCredie KB, Smith TL, Youness E, Murphy SG, Freireich EJ. Natural history of central nervous system acute leukemia in adults. Cancer. 1981;47(1):184–96.
Tian X, Fan T, Zhao W, Abbas G, Han B, Zhang K, Xie Z. Recent advances in the development of nanomedicines for the treatment of ischemic stroke. Bioact Mater. 2021;6(9):2854–69.
Seo Y, Bang S, Son J, Kim D, Jeong Y, Kim P, Kim HN. Brain physiome: a concept bridging in vitro 3D brain models and in silico models for predicting drug toxicity in the brain. Bioact Mater. 2021. https://doi.org/10.1016/j.bioactmat.2021.11.009.
Xu G, Mahajan S, Roy I, Yong KT. Theranostic quantum dots for crossing blood–brain barrier in vitro and providing therapy of HIV-associated encephalopathy. Front Pharmacol. 2013;4:140.
Derk J, Jones HE, Como C, Pawlikowski B, Siegenthaler JA. Living on the edge of the CNS: meninges cell diversity in health and disease. Front Cell Neurosci. 2021;15:703944.
Da Mesquita S, Fu Z, Kipnis J. The meningeal lymphatic system: a new player in neurophysiology. Neuron. 2018;100(2):375–88.
Zhao P, Le Z, Liu L, Chen Y. Therapeutic delivery to the brain via the lymphatic vasculature. Nano Lett. 2020;20(7):5415–20.
Price RA, Johnson WW. The central nervous system in childhood leukemia: I. Cancer. 1973;31(3):520–33.
Ma Z, Zhao X, Huang J, Jia X, Deng M, Cui D, Xiao C. A critical role of periostin in B-cell acute lymphoblastic leukemia. Leukemia. 2017;31(8):1835–7.
Erdener ŞE, Tang J, Kılıç K, Postnov D, Giblin JT, Kura S, Boas DA. Dynamic capillary stalls in reperfused ischemic penumbra contribute to injury: a hyperacute role for neutrophils in persistent traffic jams. J Cereb Blood Flow Metab. 2021;41(2):236–52.
Frishman-Levy L, Izraeli S. Advances in understanding the pathogenesis of CNS acute lymphoblastic leukaemia and potential for therapy. Br J Haematol. 2017;176(2):157–67.
Mullins N, Forstner AJ, O’Connell KS, Coombes B, Coleman JR, Qiao Z, Potash JB. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53(6):817–29.
Engelhardt B, Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood–brain barriers. Trends Immunol. 2012;33(12):579–89.
Yao Y, Chen ZL, Norris EH, Strickland S. Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity. Nat Commun. 2014;5(1):1–12.
Gétaz EP, Miller GJ. Spinal cord involvement in chronic lymphocytic leukemia. Cancer. 1979;43(5):1858–61.
Tavares GA, Louveau A. Meningeal lymphatics: an immune gateway for the central nervous system. Cells. 2021;10(12):3385.
Yuan J, Li Y, Liu X, Nie M, Jiang W, Fan Y, Jiang R. Atorvastatin plus low-dose dexamethasone may be effective for leukemia-related chronic subdural hematoma but not for leukemia encephalopathy: a report of three cases. Front Oncol. 2021;11:628927.
Olivier JC. Drug transport to brain with targeted nanoparticles. NeuroRx. 2005;2(1):108–19.
Parvez S, Kaushik M, Ali M, Alam MM, Ali J, Tabassum H, Kaushik P. Dodging blood brain barrier with “nano” warriors: Novel strategy against ischemic stroke. Theranostics. 2022;12(2):689.
Kreyling WG, Fertsch-Gapp S, Schäffler M, Johnston BD, Haberl N, Pfeiffer C, Parak WJ. In vitro and in vivo interactions of selected nanoparticles with rodent serum proteins and their consequences in biokinetics. Beilstein J Nanotechnol. 2014;5(1):1699–711.
Zhou Q, Shao S, Wang J, Xu C, Xiang J, Piao Y, Shen Y. Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy. Nat Nanotechnol. 2019;14(8):799–809.
Mady OY, Donia AA, Al-Shoubki AA, Qasim W. Paracellular pathway enhancement of metformin hydrochloride via molecular dispersion in span 60 microparticles. Front Pharmacol. 2019;10:713.
留言 (0)